Kent Shih
2PUBLICATIONS
1CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Feb 10, 2025
A phase Ib study evaluating the c-MET inhibitor INC280 (capmatinib) in combination with bevacizumab in patients with high-grade glioma.Gerald S Falchook, James D Battiste, Amandeep Kalra
|Aug 09, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).John D Hainsworth, Kevin P Becker, Tarek Mekhail
Pageof 1
